Lipella Pharmaceuticals Inc. (LIPO) Stock Forecast
LIPO analyst forecast
as of October 21, 2026- Analyst consensus
- Buy 4.00 / 5 from 1 analysts
- Price target
- $10.00 average of analyst targets
- Upside to target
- +1,999,900.0% from the latest close
- Next earnings
- —
- 52-week range
- $0.00 – $0.00
LIPO analyst ratings
1 analystsNumber of analysts at each rating.
LIPO price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
LIPO earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next fiscal year (2026) | $0.00 | $0.00 | $0.00 | — | — | — |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
LIPO revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next fiscal year (2026) | $0 | $0 | $0 | 0.0% | 1 |
LIPO EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
LIPO EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next fiscal year (2026) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | 0 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
LIPO earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; LIPO beat in 3 of 6.
What analysts expect from LIPO
1 analysts cover Lipella Pharmaceuticals; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $10.00, 1,999,900.0% above the latest close of $0.00. For 2026 the average estimate is $0.00 per share. Lipella Pharmaceuticals beat the EPS estimate in 3 of the last 6 quarters.
Related: LIPO income statement, LIPO key metrics, LIPO chart. See the LIPO stock overview for the latest quote and news.
LIPO forecast FAQ
What is Lipella Pharmaceuticals's price target?
The average analyst price target for Lipella Pharmaceuticals is $10.00, 1,999,900.0% above the latest close of $0.00.
Is Lipella Pharmaceuticals a buy, hold or sell?
Of 1 analysts covering Lipella Pharmaceuticals, 0 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
Does Lipella Pharmaceuticals usually beat earnings estimates?
Lipella Pharmaceuticals reported EPS at or above the analyst estimate in 3 of the last 6 quarters.